CBI struggling to hold a P/E of 7 despite a positive report, Berkshire ownership, oil rebound, etc.
That is what happens when the street loses all confidence in a management team and dumps a stock onto the dog pile. Nobody trusts anything they say or report.
That "science" is nothing more than classic penny stock selling BS hype presented in a way to fool folks like you into blindly buying hope while the real facts known by the street clearly point to a complete bust.
$1 is CONFIRMED!
ARWR will run out of cash long before any drug approval (which will NEVER happen anyway).
More dilution coming and more massive losses.
ARWR is another DNDN...FACT.
$1 is coming.
This one was an easy call.
Of course NOV was going to get hammered as oil headed to multi-year lows.
The problem now with NOV is the competition going forward. I think the days of "No other vendor" are over.
Very limited upside for at least the next 12-18 months.